Libre by Abbott is a continuous glucose monitoring app for diabetes patients, serving as a companion tool for proprietary hardware sensors on iOS and Android.
Product velocity
Unknown
Daily rank 🇺🇸
#16
▲2Medical · free
Sentiment
4.5
126k reviews
Nemesis
mySugr - Diabetes Tracker Log
The App DNA
What makes this app unique?
Users hire the app to automate glucose tracking and eliminate manual finger-prick testing, shifting the burden of care from active logging to passive, real-time data monitoring.
For Diabetes patients (ages 2+) and their caregivers or healthcare providers.
Key features
Generative AI food impact prediction
Automatic glucose readings every minute
Remote data sharing for caregivers
How much does it cost?
The app functions as a free utility to drive recurring revenue from prescription-only sensor hardware.
Velocity
Steady developmentShow more...
Who built it?
Abbott Labs
13+ apps tracked · Medical
FreeStyle Libre 3 – US
FreeStyle LibreLink – ZA
FreeStyle LibreLink – BE
FreeStyle LibreLink – KW
FreeStyle Libre 3 - CH
FreeStyle Libre 3 - AT
FreeStyle LibreLink – IE
FreeStyle LibreLink – MX
FreeStyle LibreLink – CO
FreeStyle Libre 3 - NO
FreeStyle LibreLink – GB
FreeStyle Libre 3 – LUUser Sentiment
What do users think recently?
Fresh user feedback skews mixed. Users appreciate real-time glucose monitoring provides freedom from manual finger-prick testing throughout the day.
How are ratings & reviews evolving?
Weekly average review rating
What users say, by theme
- Real-time glucose monitoring provides freedom from manual finger-prick testing throughout the day
- Frequent Bluetooth connection drops between the sensor and mobile device disrupt continuous data tracking
49 of 49 recent reviews analyzed · high confidence · Mixed overall
Read the full review analysisUnlock 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Libre by Abbott
How's the Medical market?
Libre by Abbott currently holds the #12 spot in the US Medical category. The gap between its high-utility sensor hardware and the mixed sentiment on connectivity suggests that market share is currently defended by hardware lock-in rather than software satisfaction.
Read the market outlookThe rivals identified
By mySugr GmbH
With over 134,000 reviews and a high release cadence, mySugr is the primary competitor for user engagement in the diabetes management space.
- Gamified logging experience increases daily user retention compared to this app's clinical-first data entry approach.
- Integrates with a wider variety of third-party glucose meters beyond this app's proprietary sensor ecosystem.
- Provides comprehensive insulin and carbohydrate tracking features that this app currently lacks.
Unlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for Libre by Abbott
Where is it heading?
The diabetes management market is shifting toward closed-loop systems that prioritize data reliability over standalone tracking. Libre by Abbott remains advantaged by its sensor ecosystem, but the current technical friction creates an opening for rivals to capture the power-user segment.
- Persistent Bluetooth connectivity failures in the latest version disrupt data tracking, which compounds the rating drag already visible on Android.
- The addition of Libre Assist AI indicates active feature investment, which differentiates the app from purely manual logging competitors.
The SWOT
- Proprietary sensor-hardware integration creates high switching costs
- LibreView clinical data management drives provider-led prescription volume
- Untapped education partnerships for B2B distribution
- Integration of insulin delivery systems for closed-loop management
Next best moves
Rebuild Bluetooth handshake logic because connection drops are the #1 complaint theme → reduce churn
+ 1 more prioritized moveThe counter-intuitive read
The app's #12 chart position is a liability, not a win…
Read the full takeFeature gaps
Gamified logging (available in mySugr) +1
Since the last report: The app introduced AI-driven features and caregiver tools but faces a decline in user trust due to new, persistent Bluetooth connectivity issues.
Bottom line
Libre by Abbott maintains its category lead through proprietary hardware, but technical instability in the latest version threatens long-term retention, so the PM must prioritize Bluetooth reliability over new AI features to prevent user migration to more stable competitors.
Unlock 3 critical frictions, 3 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeReport last updated